Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Medicure News

    0,66 € +4,76% +0,03 €
    09:20:44 Uhr Frankfurt aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1J7TZ
    ISIN: CA58469E4085
    US-Symbol: MCUJF
    Typ: Aktie

    Medicure News

    01.02.23 - PR Newswire
    MEDICURE ANNOUNCES RESIGNATION OF BOARD MEMBER AND GRANT OF STOCK OPTIONS
    MEDICURE ANNOUNCES RESIGNATION OF BOARD MEMBER AND GRANT OF STOCK OPTIONS PR Newswire
    24.11.22 - PR Newswire
    MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2022
    MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2022 PR Newswire
    17.11.22 - PR Newswire
    MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2022
    MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2022 PR Newswire
    26.09.22 - PR Newswire
    EARLY WARNING NEWS RELEASE - DR. ALBERT D. FRIESEN'S HOLDINGS IN MEDICURE INC.
    EARLY WARNING NEWS RELEASE - DR. ALBERT D. FRIESEN'S HOLDINGS IN MEDICURE INC. PR Newswire
    24.08.22 - PR Newswire
    MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED JUNE 30, 2022
    MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED JUNE 30, 2022 PR Newswire
    17.08.22 - PR Newswire
    MEDICURE TO PRESENT FINANCIAL RESULTS ON AUGUST 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED JUNE 30, 2022
    MEDICURE TO PRESENT FINANCIAL RESULTS ON AUGUST 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED JUNE 30, 2022 PR Newswire
    24.06.21 - PR Newswire
    Medicure Announces Appointment of David Gurvey as Chief Financial Officer
    Medicure Announces Appointment of David Gurvey as Chief Financial Officer PR Newswire
    10.05.21 - PR Newswire
    Medicure Reports Financial Results for Quarter Ended March 31, 2021
    Medicure Reports Financial Results for Quarter Ended March 31, 2021 PR Newswire
    05.05.21 - PR Newswire
    Medicure 2020 Annual and Q1 2021 Results and Conference Call Date
    Medicure 2020 Annual and Q1 2021 Results and Conference Call Date PR Newswire
    28.04.21 - PR Newswire
    Medicure Announces Resignation of Chief Financial Officer and Succession Plan
    Medicure Announces Resignation of Chief Financial Officer and Succession Plan PR Newswire
    20.04.21 - PR Newswire
    Medicure Reports Financial Results for Quarter and Year Ended December 31, 2020
    Medicure Reports Financial Results for Quarter and Year Ended December 31, 2020 PR Newswire
    29.03.21 - PR Newswire
    Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 30, 2021
    Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 30, 2021 PR Newswire
    08.03.21 - PR Newswire
    Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 9, 2021
    Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 9, 2021 PR Newswire
    22.02.21 - PR Newswire
    Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, February 23, 2021
    Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, February 23, 2021 PR Newswire
    04.02.21 - PR Newswire
    Medicure To Participate In Renmark's Virtual Non-Deal Roadshow Series on Monday, February 8, 2021
    Medicure To Participate In Renmark's Virtual Non-Deal Roadshow Series on Monday, February 8, 2021 PR Newswire
    27.01.21 - PR Newswire
    Medicure Announces Early Completion of Enrollment for iSPASM, a Phase 1/2a Exploratory Clinical Trial of AGGRASTAT® (tirofiban hydrochloride) Injection vs. Placebo for Induced Suppression of Platelets Activity in Aneurysmal Subarachnoid Hemorrhage Management
    Medicure Announces Early Completion of Enrollment for iSPASM, a Phase 1/2a Exploratory Clinical Trial of AGGRASTAT® (tirofiban hydrochloride) Injection vs. Placebo for Induced ...
    07.01.21 - PR Newswire
    Medicure Announces Pivotal Phase 3 Trial IND Filing with FDA for Treatment of Seizures Associated with Pyridox(am)ine 5'-phosphate oxidase (PNPO) Deficiency
    Medicure Announces Pivotal Phase 3 Trial IND Filing with FDA for Treatment of Seizures Associated with Pyridox(am)ine 5'-phosphate oxidase (PNPO) Deficiency PR Newswire
    17.12.20 - PR Newswire
    Medicure Enters the US Online Pharmacy World with Acquisition of Marley Drug
    Medicure Enters the US Online Pharmacy World with Acquisition of Marley Drug PR Newswire
    02.12.20 - PR Newswire
    Medicure Retains Investor Relations Firm Renmark Financial Communications Inc.
    Medicure Retains Investor Relations Firm Renmark Financial Communications Inc. PR Newswire
    18.11.20 - PR Newswire
    Medicure Announces Settlement of Patent Infringement Action
    Medicure Announces Settlement of Patent Infringement Action PR Newswire

    Newssuche

    Videos

    newspaper
    08:50 Uhr
    Technical Trading: AUD/USD mit Mega Chance
    AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »